According to the manufacturer, DentaBiome's mechanism centers on the FabM enzyme, linked to fatty acid biosynthesis in bacteria such as Streptococcus mutans — one of the bacteria most associated with cavity formation.
Published research on this metabolic pathway suggests that disabling this enzyme in lab settings makes oral bacteria significantly more vulnerable to destruction. That's the rationale the brand cites for its formula: instead of simply adding more "good" bacteria, the product aims to break down the defenses of the "bad" ones.
One note of honesty: these studies were conducted at the level of an isolated ingredient under controlled conditions, and there is currently no published clinical trial evaluating DentaBiome's final formula as a finished product.
Sources: research on the FabM pathway and postbiotics in microbiology/dental journals. Always consult your dentist for individual guidance.